Tata India Pharma & Healthcare Fund - Direct - Growth

Equity Scheme by Tata Asset Management Private Limited

3Y Returns (CAGR)
18.10%
Expense Ratio
1.02%

as of 01/08/2026

AUM
₹439.04 Cr

Qtr End: Jun 26

NAV
₹36.991

as of 16/10/2026

Historical Performance
Investment growth and SIP performance over time.
Performance Metrics
Returns, CAGR, and Volatility.
Period
Returns
CAGR
Volatility
3M-5.86%-21.47%10.11%
6M7.03%14.55%11.28%
1Y1.83%1.83%11.92%
3Y64.70%18.10%13.38%
5Y93.61%14.13%13.07%
Scheme Details
Launch Date
04/12/2015
Fund Age
10.9 years
Minimum Investment
₹5,000
Fund House
Tata Mutual Fund
Category
Equity Scheme
Sub-category
Sectoral/ Thematic (Equity Scheme)

Frequently Asked Questions